beovu brolucizumab (rbe) 120 mg/ml solution for injection in vial
novartis pharmaceuticals australia pty ltd - brolucizumab, quantity: 120 mg/ml - injection, solution - excipient ingredients: sodium citrate; sucrose; polysorbate 80; water for injections - beovu is indicated for the treatment of: - neovascular (wet) age-related macular degeneration (amd). - diabetic macular oedema (dme)
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - ophthalmologicals - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
meridian health supplements probiomune
eu yan sang australia pty ltd - lactobacillus acidophilus,trametes versicolor -
meridian health supplements adaptimmune
eu yan sang australia pty ltd - cordyceps sinensis -
meridian health supplements cold and flu
eu yan sang australia pty ltd - andrographis paniculata,isatis tinctoria -
meridian health supplements immunaid
eu yan sang australia pty ltd - ganoderma lucidum -
meridian health supplements stressease
eu yan sang australia pty ltd - cordyceps sinensis,ocimum tenuiflorum -
meridian health supplements jointaid
eu yan sang australia pty ltd - boswellia serrata,curcuma longa,eucommia ulmoides -
meridian balm- camphor, menthol ointment
6c23, llc - camphor 3% menthol 1% - external analgesic temporary relief from aches and pains of sore muscles & joints associated with • simple backache • strains • sprains • arthritis • bruises • rheumatism • cramp • gnats bite • itching • burn • dizziness
calcifit 500
meridian enterprises pvt. ltd - calcium carbonate; vitamin d3 - tablet, coated; oral - 1250 mg/250 iu